Connection
Kevin Lillehei to Gliosarcoma
This is a "connection" page, showing publications Kevin Lillehei has written about Gliosarcoma.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.908 |
|
|
|
-
Liu Y, Wang Q, Kleinschmidt-DeMasters BK, Franzusoff A, Ng KY, Lillehei KO. TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors. J Neurooncol. 2007 Jan; 81(2):149-62.
Score: 0.277
-
Liu Y, Ng K, Lillehei KO. Time course analysis and modulating effects of established brain tumor on active-specific immunotherapy. Neurosurg Focus. 2000 Dec 15; 9(6):e3.
Score: 0.186
-
Kong Q, Kleinschmidt-DeMasters BK, Lillehei KO. Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats. J Surg Oncol. 1998 Oct; 69(2):76-82.
Score: 0.160
-
Kong Q, Kleinschmidt-Demasters BK, Lillehei KO. Intralesionally implanted cisplatin cures primary brain tumor in rats. J Surg Oncol. 1997 Apr; 64(4):268-73.
Score: 0.144
-
Lillehei KO, Kong Q, Withrow SJ, Kleinschmidt-DeMasters B. Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatment of 9L gliosarcoma in the rat. Neurosurgery. 1996 Dec; 39(6):1191-7; discussion 1197-9.
Score: 0.141